NuVasive (NUVA) Tops Q1 EPS by 4c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NuVasive Reports First Quarter 2016 Financial Results
April 26, 2016 4:05 PM EDTSAN DIEGO, CAÂ -- (Marketwired) -- 04/26/16 --
NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended March 31, 2016.
First Quarter 2016 Highlights
Revenue increased 11.8% to $215.1 million, or 12.3% on a constant currency basis; Non-GAAP operating profit margin up 150 basis points to 14.1%; GAAP operating profit margin of 5.7%; Non-GAAP diluted earnings per share of $0.31; GAAP diluted loss per share of $0.18;... More